Shanghai Haohai Biological Technology Co., Ltd. - Laporan Laba Rugi (TTM)

Shanghai Haohai Biological Technology Co., Ltd.
HK ˙ SEHK ˙ CNE100001W69
HK$ 27.14 ↑0.42 (1.57%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Shanghai Haohai Biological Technology Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,343 1,324 1,594 1,674 1,702 1,750 1,805 1,861 2,063 2,103 2,237 2,460 2,503 2,635 2,670 2,726 2,728 2,680 2,652 2,580
Change (%) -1.38 20.33 5.06 1.64 2.84 3.15 3.06 10.90 1.95 6.33 9.99 1.73 5.28 1.32 2.13 0.05 -1.77 -1.02 -2.74
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 312 334 405 431 453 490 527 563 638 657 686 755 745 788 813 831 840 843 833 819
Change (%) 7.11 21.28 6.44 5.00 8.32 7.41 6.90 13.34 2.88 4.49 10.10 -1.43 5.85 3.12 2.29 1.04 0.37 -1.23 -1.66
% of Revenue 23.22 25.22 25.42 25.75 26.60 28.02 29.18 30.26 30.93 31.21 30.67 30.70 29.75 29.91 30.44 30.49 30.79 31.46 31.40 31.75
Gross Operating Profit 1,031 990 1,189 1,243 1,249 1,260 1,279 1,297 1,425 1,447 1,551 1,705 1,758 1,847 1,857 1,895 1,888 1,837 1,819 1,761
Change (%) -3.95 20.02 4.59 0.47 0.86 1.50 1.47 9.84 1.53 7.16 9.95 3.13 5.04 0.55 2.06 -0.38 -2.72 -0.93 -3.23
% of Revenue 76.78 74.78 74.58 74.25 73.40 71.98 70.82 69.74 69.07 68.79 69.33 69.30 70.25 70.09 69.56 69.51 69.21 68.54 68.60 68.25
SG&A 854 772 793 733 759 898 982 1,065 1,132 1,085 1,116 1,176 1,194 1,237 1,223 1,224 1,214 1,228 1,228 1,215
Change (%) -9.54 2.69 -7.55 3.52 18.35 9.30 8.51 6.29 -4.21 2.90 5.32 1.57 3.58 -1.15 0.11 -0.78 1.10 -0.02 -1.02
% of Revenue 63.59 58.33 49.77 43.80 44.61 51.34 54.39 57.27 54.89 51.57 49.91 47.79 47.72 46.94 45.80 44.89 44.52 45.82 46.29 47.10
R&D 121 126 135 143 156 168 169 171 175 182 197 207 215 220 231 244 254 239 222 212
Change (%) 4.74 6.63 6.32 8.88 7.35 0.96 0.95 2.48 4.07 8.38 4.77 3.99 2.31 5.12 5.50 4.09 -5.96 -6.90 -4.73
% of Revenue 8.99 9.55 8.46 8.56 9.17 9.58 9.37 9.18 8.49 8.66 8.83 8.41 8.60 8.35 8.67 8.95 9.31 8.92 8.39 8.22
OpEx 1,307 1,232 1,333 1,327 1,389 1,553 1,673 1,793 1,918 1,939 2,008 2,140 2,170 2,243 2,272 2,311 2,329 2,308 2,283 2,250
Change (%) -5.79 8.24 -0.46 4.66 11.85 7.73 7.17 6.95 1.11 3.53 6.61 1.41 3.35 1.29 1.73 0.78 -0.93 -1.05 -1.48
% of Revenue 97.34 92.99 83.64 79.25 81.60 88.75 92.68 96.38 92.95 92.19 89.76 87.00 86.72 85.13 85.10 84.78 85.39 86.12 86.09 87.21
Operating Income 36 93 261 347 313 197 132 67 145 164 229 320 332 392 398 415 399 372 369 330
Change (%) 160.30 180.83 33.28 -9.90 -37.10 -32.92 -49.08 116.23 13.03 39.34 39.67 3.89 17.89 1.50 4.39 -3.98 -6.67 -0.86 -10.55
% of Revenue 2.66 7.01 16.36 20.75 18.40 11.25 7.32 3.62 7.05 7.81 10.24 13.00 13.28 14.87 14.90 15.22 14.61 13.88 13.91 12.79
Interest Expense -5 -5 -6 -5 -4 -5 -5 -6 -5 -8 -7 -9 -9 -7 -9 -11 -12 -18 -18 -16
Change (%) -7.57 16.33 -11.64 -17.10 18.74 9.77 8.90 -12.81 46.97 -3.09 18.12 5.93 -20.87 22.20 25.04 5.07 54.22 -0.83 -9.35
% of Revenue -0.40 -0.37 -0.36 -0.30 -0.25 -0.28 -0.30 -0.32 -0.25 -0.36 -0.33 -0.35 -0.37 -0.28 -0.33 -0.41 -0.43 -0.67 -0.68 -0.63
Net Income 232 230 370 434 428 352 272 192 203 180 226 315 346 416 432 446 430 420 413 396
Change (%) -0.99 61.01 17.04 -1.30 -17.69 -22.71 -29.38 5.85 -11.31 25.30 39.15 9.80 20.43 3.93 3.16 -3.58 -2.27 -1.72 -4.11
% of Revenue 17.30 17.37 23.24 25.89 25.15 20.13 15.08 10.33 9.86 8.58 10.11 12.79 13.81 15.79 16.20 16.36 15.77 15.69 15.58 15.36

Source: Capital IQ

Other Listings
DE:5HB € 2.92
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista